- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Zydus Lifesciences Limited — Updates, 28-05-2026: Press Release
28-05-2026 | 06:04 pm
28-05-2026 | 06:04 pm
Zydus Lifesciences subsidiary's Saroglitazar for PBC gained US FDA Priority Review with strong Phase 3 data. Potential US launch by Q4 FY27 could open a significant new revenue stream.
No comments yet. Be the first to comment!